BDSI prices $15 million private placement BioDelivery Sciences International, Inc. announces that it offers received definitive commitments from institutional traders for an exclusive placement funding yielding gross proceeds of $15 million to BDSI canadian pharmacy more info .12 per talk about, representing a 10 percent low cost to an arranged volume weighted average cost of BDSI’s share.S. Exchange and Securities Commission. Arises from this financing are anticipated to be utilized to advance the clinical advancement of BDSI’s pipeline of items, bEMA Buprenorphine and BEMA Buprenorphine/Naloxone particularly. William Blair & Firm, LLC acted because the exclusive positioning agent for the providing.